City

Bethesda (1)

Condition

Chronic Granulomatous Disease Transplant (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Collaborator

Intervention

alemtuzumab (1)

busulfan (1)

cyclophosphamide (1)

peripheral blood stem cells (1)

sirolimus (1)

total body irradiation (1)

Study Documents

Intervention Type

biological (1)

drug (1)

radiation (1)

Funder Type

NIH (1)

Study Type

Interventional (1)

chronic granulomatous disease transplant

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

Active, not recruiting

Chronic Granulomatous Disease Transplant

Alemtuzumab
+5 more

Bethesda, Maryland

National Institutes of Health Clinical Center

Jan 21, 2023